These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24152650)

  • 1. PET/CT study performed after an oral administration of 18F-fluoride.
    Zacchi SR; Valadares AA; Duarte PS; Sapienza MT; Buchpiguel CA
    Clin Nucl Med; 2013 Dec; 38(12):1012-4. PubMed ID: 24152650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary Comparison of PET/CT Studies Performed After Intravenous and Oral Administration of 18F-Fluoride.
    Zacchi SR; do Vale RH; Duarte PS; Sapienza MT; Buchpiguel CA
    Clin Nucl Med; 2016 Jan; 41(1):79-80. PubMed ID: 26545027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F sodium fluoride PET/CT detects osseous metastases from breast cancer missed on FDG PET/CT with marrow rebound.
    Avery R; Kuo PH
    Clin Nucl Med; 2013 Sep; 38(9):746-8. PubMed ID: 23797230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma.
    Chakraborty D; Bhattacharya A; Mete UK; Mittal BR
    Clin Nucl Med; 2013 Aug; 38(8):616-21. PubMed ID: 23603596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.
    Kjölhede H; Ahlgren G; Almquist H; Liedberg F; Lyttkens K; Ohlsson T; Bratt O
    BJU Int; 2012 Nov; 110(10):1501-6. PubMed ID: 22502982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A literature review of 18F-fluoride PET/CT and 18F-choline or 11C-choline PET/CT for detection of bone metastases in patients with prostate cancer.
    Wondergem M; van der Zant FM; van der Ploeg T; Knol RJ
    Nucl Med Commun; 2013 Oct; 34(10):935-45. PubMed ID: 23903557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-Fluoride PET/CT in the detection of bone metastases in clear cell renal cell carcinoma: discordance with bone scintigraphy.
    Fuccio C; Spinapolice EG; Cavalli C; Palumbo R; D'Ambrosio D; Trifirò G
    Eur J Nucl Med Mol Imaging; 2013 Dec; 40(12):1930-1. PubMed ID: 23877634
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone metastases from prostate cancer: 18F-fluoride PET/CT in a patient with discordant bone scintigraphy and 11C-choline PET/CT.
    Garcia G; Riera E; Valls E; Soler M; Bassa P; Moragas M; Lomeña F
    Clin Nucl Med; 2013 Feb; 38(2):120-4. PubMed ID: 23334127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effect of 89Sr for multiple bone metastases of breast cancer: diagnosis by 18F-FDG PET/CT.
    Hama Y
    Clin Nucl Med; 2014 Apr; 39(4):e290-1. PubMed ID: 23917785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-Fluoride positron emission tomography and positron emission tomography/computed tomography.
    Even-Sapir E; Mishani E; Flusser G; Metser U
    Semin Nucl Med; 2007 Nov; 37(6):462-9. PubMed ID: 17920353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-Fluoride PET/CT for detection of bone metastasis in patients with renal cell carcinoma: a pilot study.
    Sharma P; Karunanithi S; Chakraborty PS; Kumar R; Seth A; Julka PK; Bal C; Kumar R
    Nucl Med Commun; 2014 Dec; 35(12):1247-53. PubMed ID: 25171438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal metastases from breast cancer: uptake of 18F-fluoride measured with positron emission tomography in correlation with CT.
    Petrén-Mallmin M; Andréasson I; Ljunggren O; Ahlström H; Bergh J; Antoni G; Långström B; Bergström M
    Skeletal Radiol; 1998 Feb; 27(2):72-6. PubMed ID: 9526771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glioblastoma multiforme metastastic to the bone: diagnosis by (18)F-NaF PET/CT.
    Derlin T; Clauditz TS; Bannas P
    Clin Nucl Med; 2014 Feb; 39(2):188-9. PubMed ID: 24300358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ¹⁸F-fluoride PET/computed tomography imaging.
    Even-Sapir E
    PET Clin; 2014 Jul; 9(3):277-85. PubMed ID: 25030391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases.
    Iagaru A; Young P; Mittra E; Dick DW; Herfkens R; Gambhir SS
    Clin Nucl Med; 2013 Jul; 38(7):e290-6. PubMed ID: 23455520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-Fluoride PET/CT allows detection of hyperostosis and osseous involvement in meningioma: initial experience.
    Tateishi U; Tateishi K; Shizukuishi K; Shishikura A; Murata H; Inoue T; Kawahara N
    Clin Nucl Med; 2013 Mar; 38(3):e125-31. PubMed ID: 23412601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
    Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
    J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT.
    Even-Sapir E; Metser U; Flusser G; Zuriel L; Kollender Y; Lerman H; Lievshitz G; Ron I; Mishani E
    J Nucl Med; 2004 Feb; 45(2):272-8. PubMed ID: 14960647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT.
    Piccardo A; Puntoni M; Morbelli S; Massollo M; Bongioanni F; Paparo F; Altrinetti V; Gonella R; Gennari A; Iacozzi M; Sambuceti G; DeCensi A
    Nuklearmedizin; 2015; 54(4):163-72. PubMed ID: 26165806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of 18F-fluoride PET/CT and 18F-FDG PET/CT in the detection of bony metastases in heightened-risk head and neck cancer patients.
    Chan SC; Wang HM; Ng SH; Hsu CL; Lin YJ; Lin CY; Liao CT; Yen TC
    J Nucl Med; 2012 Nov; 53(11):1730-5. PubMed ID: 22961077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.